Article Details

$110 Million Awarded for Sudan Ebolavirus Therapeutic Development

Retrieved on: 2022-10-08 11:18:33

Tags for this article:

Click the tags to see associated articles and topics

$110 Million Awarded for Sudan Ebolavirus Therapeutic Development. View article details on hiswai:

Excerpt

MBP134 is the first combination of monoclonal antibodies (mAbs) in BARDA's ... monoclonal antibody therapeutic to treat Sudan ebolavirus (SUDV).

Article found on: www.precisionvaccinations.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up